DNAJC31 (DnaJ Heat Shock Protein Family (Hsp40) Member C31) is a member of the DnaJ/Hsp40 family of co-chaperones involved in cellular protein quality control pathways. The DNAJC31 protein contains the characteristic J domain that enables interaction with Hsp70 heat shock proteins, facilitating protein folding, refolding of stress-damaged proteins, and targeting of misfolded proteins for degradation. This gene is expressed in various tissues, with expression in the brain suggesting potential roles in neuronal protein homeostasis. The protein quality control functions of DNAJC31 may be particularly relevant to neurodegenerative disease mechanisms, where proteostasis failure is a key pathological feature.
| Property | Value |
|---|---|
| Gene Symbol | DNAJC31 |
| Full Name | DnaJ Heat Shock Protein Family (Hsp40) Member C31 |
| Chromosomal Location | 17q25.3 |
| Gene ID | 345222 |
| RefSeq | NM_001012506 |
| Protein Length | 298 amino acids |
| Molecular Weight | ~32 kDa |
| Alternative Names | DNAJC31, DJC31 |
DNAJC31 contains the canonical DnaJ protein domain architecture:
J domain: The N-terminal domain (approximately 70 amino acids) contains the highly conserved HPD (His-Pro-Asp) motif essential for stimulating Hsp70 ATPase activity. This domain mediates the interaction with Hsp70 family proteins.
Glycine-rich flexible region: A flexible linker region between the J domain and C-terminal regions that facilitates protein-protein interactions and provides structural flexibility.
C-terminal client-binding domain: The C-terminal region is predicted to be involved in recognizing and binding unfolded or misfolded client proteins, containing regions that may form coiled-coil structures.
The domain organization follows the typical DnaJ family pattern, with the catalytic J domain at the N-terminus connected to the client-binding region through a flexible glycine-rich linker.
DNAJC31 shows broad expression across tissues:
Brain: Expressed in various brain regions including the cerebral cortex, hippocampus, basal ganglia, and cerebellum. Both neuronal and glial cell expression has been detected.
Peripheral tissues: Moderate expression in heart, liver, kidney, and skeletal muscle.
Cellular localization: Primarily cytosolic localization, consistent with roles in general protein quality control throughout the cell.
The widespread expression pattern suggests DNAJC31 serves general protein homeostasis functions that are essential across multiple tissue types, with particular importance in cells with high protein synthesis rates.
DNAJC31 functions as a co-chaperone in protein quality control:
Hsp70 recruitment and activation: The J domain interacts with and stimulates Hsp70 ATPase activity, enabling client protein processing.
Substrate recognition: The C-terminal domains recognize hydrophobic regions in misfolded or partially unfolded proteins.
Protein folding support: DNAJC29 can stabilize folding intermediates and prevent aggregation during the folding process.
Targeted degradation: DNAJC31 can direct misfolded proteins to the ubiquitin-proteasome system (UPS) or autophagy pathways for degradation.
DNAJC31 participates in several cellular processes:
Based on its protein quality control functions, DNAJC31 may play roles in neurodegenerative diseases:
DNAJC31 represents a potential therapeutic target:
Chaperone enhancement: Small molecules that enhance DNAJC31 function could improve protein clearance in neurodegeneration.
Expression modulation: Increasing DNAJC31 expression may bolster cellular protein quality control capacity.
Combination therapy: Targeting DNAJC31 with other proteostasis components may provide synergistic benefits.
Biomarker potential: DNAJC31 expression levels could serve as indicators of proteostatic stress.
Investigating DNAJC31 involves:
DNAJC31 is a DnaJ/Hsp40 family co-chaperone involved in cellular protein quality control. Through its J domain-mediated interaction with Hsp70 proteins, DNAJC31 facilitates protein folding, prevents protein aggregation, and targets misfolded proteins for degradation. The expression of DNAJC31 in the brain suggests potential relevance to neuronal protein homeostasis, which is critical for neuronal survival given their post-mitotic nature. While specific roles in neurodegenerative diseases require further investigation, the fundamental importance of protein quality control in neurodegeneration makes DNAJC31 a protein of interest. Understanding DNAJC31's specific functions, client proteins, and regulatory mechanisms may provide insights into therapeutic strategies for enhancing neuronal proteostasis in disease states.